Keyphrases
Targeting Cancer
100%
Immunosuppression
100%
Ovarian Cancer
100%
CXCR4 Antagonist
100%
Oncolytic Virotherapy
100%
Cancer Growth
100%
CXCL12-CXCR4
100%
Cancer Initiating Cells
100%
Oncolytic Vaccinia Virus
75%
Tumor
50%
Reduced Expression
25%
Myeloid Cells
25%
Metastatic Spread
25%
Overall Survival
25%
Endothelial Cells
25%
Regulatory T (Treg) Cells
25%
SCID Mice
25%
Tumor Model
25%
Anti-tumor Response
25%
CD117
25%
Tumor Angiogenesis
25%
Tumor-free Survival
25%
Vascular Endothelial Growth Factor
25%
Human Ovarian Cancer Cell
25%
Interleukin-10
25%
Antitumor
25%
Interferon-γ
25%
Cluster of Differentiation 44 (CD44)
25%
C-X-C Chemokine Receptor Type 4 (CXCR4)
25%
C-kit
25%
Cancer Development
25%
Tumor Inhibition
25%
Peritoneal Metastasis
25%
Xenograft Model
25%
Plasmacytoid Dendritic Cells
25%
Tumor-infiltrating Lymphocytes
25%
Antitumor Efficacy
25%
Oncolysis
25%
Chemokine Ligand 12 (CXCL12)
25%
Ovarian Carcinoma Cells
25%
High Ratio
25%
Hyaluronan Receptor
25%
Immunosuppressive Network
25%
Armed Virus
25%
Chemokine CXCL12
25%
Spheroid Cells
25%
Ovarian Cancer-initiating Cells
25%
Peritoneal Dissemination
25%
Stem Cell Factor Receptor
25%
Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
100%
Immunosuppressive Treatment
100%
Cancer Growth
100%
Ovarian Cancer
100%
Chemokine Receptor CXCR4 Antagonist
100%
Oncolytic Virotherapy
100%
Vaccinia Virus
75%
Krukenberg Tumor
50%
T Lymphocyte
25%
Myeloid Cell
25%
Overall Survival
25%
Endothelial Cell
25%
Immunosuppressive Drug
25%
SCID Mouse
25%
Tumor Model
25%
Ovarian Cancer Cell Line
25%
Xenograft
25%
Vasculotropin
25%
Tumor Angiogenesis
25%
Tumor Progression
25%
Stromal Cell Derived Factor 1
25%
Interleukin 10
25%
Peritoneum Metastasis
25%
Plasmacytoid Dendritic Cell
25%
Carcinoma Cell
25%
Regulatory T Cell
25%
Chemokine Receptor CXCR4
25%
Hyaluronic Acid Binding Protein
25%
Stem Cell Factor Receptor
25%
Spheroid Cell
25%
Virus
25%